sulfur has been researched along with Parkinson Disease in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (30.77) | 18.7374 |
| 1990's | 1 (7.69) | 18.2507 |
| 2000's | 3 (23.08) | 29.6817 |
| 2010's | 3 (23.08) | 24.3611 |
| 2020's | 2 (15.38) | 2.80 |
| Authors | Studies |
|---|---|
| Campos-Peña, V; Corona-Trejo, A; Daniel Reyes-Hernández, O; Figueroa-González, G; Gonsebatt, ME; Hernández-Abad, VJ; Quintas-Granados, LI; Silva-Adaya, D; Trejo-Solis, C; Villegas-Vázquez, EY | 1 |
| Baldini, F; Fleming, RMT; Glaab, E; Hankemeier, T; Harms, AC; Heinken, A; Hertel, J; Krüger, R; Langenberg, C; Mollenhauer, B; Pietzner, M; Stewart, ID; Thiele, I; Thinnes, CC; Trenkwalder, C; Vasco, DA; Wareham, NJ | 1 |
| Berry, TM; Moustafa, AA | 1 |
| Badillo-Ramírez, I; Rivas-Arancibia, S; Saniger, JM | 1 |
| Cacciatore, I; Cantalamessa, F; Cerasa, LS; Cornacchia, C; Di Stefano, A; Falcioni, ML; Gabbianelli, R; Iannitelli, A; Nasuti, C; Pinnen, F; Sekar, D; Sozio, P | 1 |
| Crippa, PR; Eisner, M; Morante, S; Stellato, F; Vicentin, FC; Zecca, L | 1 |
| Steventon, GB; Waring, RH; Williams, AC | 1 |
| Wróblewski, R | 1 |
| Kimula, Y; Tomonaga, M; Utsuyama, M; Yoshimura, M | 1 |
| Costi, P; Ito, S; Mecacci, C; Sonnino, S; Terreni, M; Zecca, L | 1 |
| Edström, L; Gremski, W; Wróblewski, R | 1 |
| Duckett, S; Galle, P; Kradin, R | 1 |
| Steventon, G; Sturman, S; Waring, R; Williams, A | 1 |
3 review(s) available for sulfur and Parkinson Disease
| Article | Year |
|---|---|
Transsulfuration pathway: a targeting neuromodulator in Parkinson's disease.
Topics: Cystathionine beta-Synthase; Cysteine; Glutathione; Humans; Parkinson Disease; Sulfur | 2023 |
5-S-cysteinyl-dopamine, a neurotoxic endogenous metabolite of dopamine: Implications for Parkinson's disease.
Topics: alpha-Synuclein; Biomarkers; Dopamine; Dopaminergic Neurons; Endoplasmic Reticulum Stress; Humans; Metabolic Networks and Pathways; Mitochondria; Nerve Tissue Proteins; Neuroprotective Agents; Oxidation-Reduction; Oxidative Stress; Parkinson Disease; Pars Compacta; Sulfur | 2019 |
Healthy and diseased striated muscle studied by analytical scanning electron microscopy with special reference to fibre type.
Topics: Adenosine Triphosphatases; Animals; Arthritis, Rheumatoid; Electron Probe Microanalysis; Elements; Extracellular Space; Female; Freeze Drying; Freezing; Humans; Male; Microscopy, Electron, Scanning; Mitochondria, Muscle; Muscle Spindles; Muscles; Muscular Diseases; Myofibrils; Parkinson Disease; Rigor Mortis; Sarcoplasmic Reticulum; Shock, Hemorrhagic; Sulfur | 1982 |
1 trial(s) available for sulfur and Parkinson Disease
| Article | Year |
|---|---|
Integrated Analyses of Microbiome and Longitudinal Metabolome Data Reveal Microbial-Host Interactions on Sulfur Metabolism in Parkinson's Disease.
Topics: Aged; Female; Gastrointestinal Microbiome; Humans; Longitudinal Studies; Male; Middle Aged; Parkinson Disease; Sulfur | 2019 |
9 other study(ies) available for sulfur and Parkinson Disease
| Article | Year |
|---|---|
A novel treatment strategy to prevent Parkinson's disease: focus on iron regulatory protein 1 (IRP1).
Topics: Aconitate Hydratase; Animals; Iron; Iron Regulatory Protein 1; Parkinson Disease; Rats; Rotenone; Sulfur | 2023 |
Codrugs linking L-dopa and sulfur-containing antioxidants: new pharmacological tools against Parkinson's disease.
Topics: Analysis of Variance; Animals; Antioxidants; Antiparkinson Agents; Area Under Curve; Chromatography, High Pressure Liquid; Corpus Striatum; Half-Life; Humans; Injections, Intraventricular; Levodopa; Parkinson Disease; Rats; Spectrophotometry, Ultraviolet; Sulfur | 2009 |
An XAS study of the sulfur environment in human neuromelanin and its synthetic analogs.
Topics: Cell Count; Humans; Male; Melanins; Neurons; Parkinson Disease; Sulfur; X-Ray Absorption Spectroscopy | 2010 |
An investigation into the inter-relationships of sulphur xeno-biotransformation pathways in Parkinson's and motor neurone diseases.
Topics: Acetaminophen; Adult; Aged; Aged, 80 and over; Biotransformation; Carbocysteine; Erythrocytes; Female; Humans; Male; Methylation; Methyltransferases; Middle Aged; Motor Neuron Disease; Oxidation-Reduction; Parkinson Disease; Phenotype; Sulfur | 2003 |
Element analysis of Lewy and adrenal bodies in Parkinson's disease by electron probe microanalysis.
Topics: Adrenal Glands; Aged; Calcium; Electron Probe Microanalysis; Female; Humans; Locus Coeruleus; Male; Parkinson Disease; Phosphorus; Sulfur | 1983 |
Interaction of human substantia nigra neuromelanin with lipids and peptides.
Topics: Aged; Aged, 80 and over; Amino Acids; Corpus Callosum; Endopeptidase K; Humans; Lipid Metabolism; Magnetic Resonance Spectroscopy; Melanins; Middle Aged; Neuropeptides; Parkinson Disease; Protein Binding; Protons; Substantia Nigra; Sulfur | 2000 |
Sulphur and phosphorus content in relation to fibre composition and atrophy of skeletal muscle in patients with Parkinson's disease.
Topics: Adenosine Triphosphatases; Adult; Aged; Atrophy; Female; Histocytochemistry; Humans; Male; Middle Aged; Muscles; NADH Tetrazolium Reductase; Parkinson Disease; Phosphorus; Succinate Dehydrogenase; Sulfur | 1979 |
The relationship between Parkinson syndrome and vascular siderosis: an electron microprobe study.
Topics: Aged; Aluminum; Barium; Calcium; Cerebral Arterial Diseases; Electron Probe Microanalysis; Female; Globus Pallidus; Humans; Iron; Lead; Magnesium; Male; Manganese; Middle Aged; Parkinson Disease; Phosphorus; Potassium; Siderosis; Sulfur; Zinc | 1977 |
Xenobiotic enzyme profiles and Parkinson's disease.
Topics: Animals; Humans; Methylation; Methyltransferases; Monoamine Oxidase; MPTP Poisoning; Parkinson Disease; Sulfur; Xenobiotics | 1991 |